The MAP Guideline was developed by Dr Trevor Brown, Dr Adam Fox, Dr Neil Shah, Dr Carina Venter and Dr Joanne Walsh.
Members of the group were involved in both the NICE Food Allergy Guideline¹, and the Department of Health commissioned RCPCH National Care Pathways for Allergic Disease in Children2, both of which highlighted the key role of primary care in the diagnosis and management of CMA. The MAP Guideline was developed by drawing from the group’s clinical expertise and their experiences in the development of these two projects.
It was decided that the two key tasks of the MAP Guideline would be to aid in the:
1. Recognition of infants presenting in primary care with suspected CMA that would benefit from early referral
2. Delivery of clear and practical guidance on how infants with mild to moderate non-IgE-mediated CMA could remain in primary care, where having first had their diagnosis carefully confirmed, they could then continue to be managed
The MAP Guideline was developed independently by its authors, and was not commissioned or in any way financially supported by any commercial sponsor
Meet the authors below:
Trevor was a member of the NICE Food Allergy Guideline Development Group, the NICE Anaphylaxis Guideline Development Group and the RCPCH National Food Allergy Care Pathway Development Group. He is a member of the Northern Ireland Paediatric Respiratory and Allergy Service Network, and Executive Member of the Primary Care Group of the British Society for Allergy and Clinical Immunology.
Adam was a member of the NICE Food Allergy Guideline Development Group, chaired the 2012 NICE Guideline Evidence Update and remains on the NICE Evidence Resources Reference Panel. He also Chaired the RCPCH National Food Allergy Care Pathway Development Group, and is secretary of the British Society for Allergy and Clinical Immunology, as well as director of the King’s College London Allergy Academy.
Neil is involved in the development of regional/national guidelines for practical identification and treatment of GI allergy. He leads a large prospective research study on GI food allergy called the Burden project. Dr Shah has trained and collaborates with Cincinnati Children’s Eosinophilic division and also leads the genetic identification of rare gastrointestinal conditions with two PhD students working on early onset inflammatory bowel disorders. He is also co-director of the Academy of Paediatric Gastroenterology, which deliver 10 courses per year in the several areas of paediatric gastroenterology.
Carina was a member of the NICE Food Allergy Guideline Development Group and the UK National Eczema Paediatric Care Pathway Development Group. She is Chair of the Food Allergy and Intolerance Interest Group of the British Dietetic Association and a Council Member of the British Society of Allergy and Clinical Immunology.
Joanne was a member of the NICE Food Allergy Guideline Development Group and the RCPCH National Food Allergy Care Pathway Development Group, and is part of the Primary Care Group of the British Society for Allergy and Clinical Immunology.
1. NICE. Diagnosis and assessment of food allergy in children and young people in primary care and community settings [Online]. 2011. Available at: www.nice.org.uk/CG116 [Accessed Sept 2013].
2. Fox AT, Lloyd K, Arkwright PD. The RCPCH care pathway for food allergy in children: an evidence and consensus based national approach. Arch Dis Child 2011;96(Suppl 2):i25-9.